Five Year Survival of Women with Breast Cancer in Ardabil,

North-West of Iran by فولادی, نسرین et al.
Five Year Survival of Women with Breast Cancer in Ardabil, North - West of Iran 
Asian Pacific Journal of Cancer Prevention 1869
RESEARCH COMMUNICATION
Five Year Survival of Women with Breast Cancer in Ardabil, 
North-West of Iran 
Nasrin Fouladi, Firouz Amani*, Afshan S Harghi, Noushin Nayebyazdi
Abstract
 Breast cancer is the most common cancer in women, and the major cause of cancer deaths in women 
20- 59 years old. The present retrospective study was undertaken to examine survival in all newly diagnosed 
breast cancer in Iran. One hundred and sixty-one breast cancer registered patients in 2003 were included 
in the study and followed up for 5-years from cancer diagnosis. Data were analyzed using life tables and 
Kaplan Meier for estimating relative survival rates and Cox’s proportional hazard model to investigate the 
interaction between variables. The mean age of the patients at diagnosis was 45.5 (SD=12.3), ranging from 
19 to 86 years.  Of all patients 90 (56%) were alive and 71( 44%) were dead after five years. Using life table 
analysis, the overall relative 5-year survival rate was found to be 51% (SE=0.05). Using Cox regression 
model analysis variables such as age, surgery, location and drug therapy significantly influenced survival. 
According to the results, the overall 5-year survival rate in Ardebil province was lower than other places 
of Iran and most countries in the world and needs to be improved. Also, results showed that breast cancer 
screening programs, awareness regarding early detection of breast cancer and education of health care 
providers are necessary.
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Introduction
 Breast cancer is the most common cancer in women. 
The mean age of breast cancer patients in Iran, similar 
to Middle East countries, is ten years lower than other 
countries in the world. Moreover, due to lack of doing 
screening tests, most of patients referred for cure in 
the advanced stages of cancer (Brunicardi et al.,2010). 
During the last fifty years, the changes in human life- 
style have been caused to increase the incidence and 
prevalence rate of breast cancer and different risk 
factors in the world (Fathi et al.,2004). According to 
Iranian ministry of health statistics, breast cancer 
remains the most common cancer among Iranian women 
and now, more than 40000 patients are suffering and 
annually over 7000 patients are added to their number. 
According to the last reports, breast cancer has become 
in first place between diseases among women. Now, the 
risk factors of breast cancer not fully specified but there 
are several etiological factors that affect the survival of 
patients. 
 According to latest statistics, age of diseases in 
Iranian women was decreased about ten years and reach 
from 40 to 30.  Annually, more than 1100 new cases 
of cancers are recorded in women of Ardabil province 
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and of these 600 deaths occur. The most common 
cancers among women are stomach, esophagus and 
breast, respectively. Age standardized incidence rate 
(ASR) of breast cancer in Ardabil province was 11.9 
per 100000 from 2004 to 2006 (Registry cancer, 2008). 
Breast cancer is one of the most common cause of 
death among middle-aged women in both developed 
and developing countries but not common in adult 
women younger than 25, so its incidence rate increase 
rapidly to age 50 and older. In the recent sixty years, the 
mortality rate from breast cancer has been increased in 
all countries (Brunicardi et al.,2010; Esteve et al.,1990) 
). Nowadays; breast cancer is considered as a social 
problem in all societies and one of the main causes of 
death among women after the lung cancer. 
 The survival of patient is one of the main criteria for 
disease control and measuring the effect of treatments. 
The survival rate for breast cancer indicates the 
percentage of people survive the disease for a specified 
period of time after diagnosis. In most cases, statistics 
refer to the 5 year survival rate for breast cancer. The 
5-year survival rate is the percentage of people who 
are alive 5 years after a breast cancer diagnosis. There 
are different methods for estimating the survival rate 
of patients. Usually, in a specified period and based on 
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registered cancer data, the relative survival is estimated 
rather than overall survival (Ederer et al., 1961; 
Heinavaara et al., 2002; Anderson et al., 2003).  Several 
studies in the world have been reported different 
rates of survival for breast cancer. In communities 
with limited access to medical facilities, screening of 
breast cancer could identify   the disease in the early 
stages and to cause improving prognosis, increasing 
survival rate and reduce mortality rate. Differences 
in incidence, mortality and survival in regions of the 
world because of differences in risk factors, need 
access to effective treatments and organized screening 
programs (Anderson et al., 2003). Different treatments 
including surgery, radiotherapy and chemotherapy 
based on disease severity for breast cancer treatment 
exist and prognosis of breast cancer has fundamental 
relation with stage of disease at diagnosis (Gizlic et 
al.,1997; Lynn et al., 2006). The object of this study 
was to measure the five-year survival and determines 
effective factors in Ardabil breast cancer patients who 
registered in Ardabil cancer registry.
 
Materials and Methods
 This was a retrospective study to examine survival 
rate in Ardabil registry cancer. One hundred and sixty-
one registered breast cancer patients with a confirmed 
pathological report diagnosed at 2003 were entered 
into the study and followed up for five years from 
2003 to 2008. Necessary data such as age at diagnosis, 
sex, residence place, treatment, tumor type and status 
of patient’s survival or die have been collected by a 
questionnaire and for patients with incomplete data, 
required information completed by telephone and 
interview. Collected data were analyzed using life table 
analysis to estimate the overall relative survival rate, 
Cox regression model to investigate the interaction 
between variables on survival and log - rank test for 
compare survival rates by variables. 
Results
 Of the 161 patients with breast cancer, 2 (1.24%) 
were male and 159 (98.74%) were female with sex ratio 
about 1 to 80. The mean age of the patients at diagnosis 
was 45.5 (SD=12.3), ranging from 19 to 86 years. Of 
these, at five years 90 (56%) were alive and 71(44%) 
were dead after five years. The mean survival time 
was 55 (SD=2.8) months ranging from 0 to 89 months. 
Using the life table analysis the overall 5- year relative 
survival rate was found to be 51% (SE=0.05) (Figure 1). 
Of these, 80 % (with 41.4% mortality) were in the age 
group of 19-35.  Breast involvement in 72 cases (44.7%) 
was in right and in 89 cases (55.3%) were in left breast. 
From all patients, 123 (76.4%) have Duct Carcinoma 
Infiltrative and 38(23.6%) have other tumors. Out of all 
cases, 115 (71.4%) were in urban areas with mortality 
rate 34.8% and 46 (28.6%) were in rural areas with 
Table 1. Cox Regression Model Results 
Variables           B     SE        sig      Exp(B)
Age at diagnosis 0.055 0.3 0.049 1.06
Surgery -1.63 0.36 0.001 0.2
Drug -0.98 0.38 0.01 1.9
Residence place 0.58 0.024 0.025 1.79
	  
Figure 2. Survival Rate by Residence Place
	  
Figure 1. The Five – year Survival Rates in Patients 
	  Figure 3. Survival Rate by Drug Use       
	  Figure 4. Survival Rate by Residence Place
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mortality rate 67.4% which in urban patients, chance of 
survival was two times more than rural patients (Figure 
2). Mortality rates in mastectomy group were 44.5% and 
in lumpectomy group was zero. Patients receiving drugs 
with mortality rate 18.5% had twice chance of survival 
than people who not received drugs (Figure 3). Patients 
undergoing surgery with mortality rate % 39 have 2.3 
chance of survival more than people who not received 
any surgical treatment (Figure 4). Finally performing 
the Cox regression analysis, variables such as place of 
residence (P=0.011), surgical treatment (P=0.001), drug 
treatment (P=0.004) and age at diagnosis (P=0.01) have 
significant effect on survival of patients (Table 1). 
Discussion
 This was a retrospective study of breast cancer 
patients in Ardabil province of Iran and the overall 
5-year relative survival rate was found to be 51%. 
The study was carried out based on data collected 
from a single cancer registry in Ardabil province with 
incomplete data forms and therefore the findings could 
not be generalized. However, the results showed that, 
the mean age at diagnosis was 45.5 years which have 
the similar pattern with other studies conducted in Iran 
and was lower nearly two decades less than America 
and Canada may be due to low age of breast cancer 
incidence in Ardabil province and Iran, compared with 
developed countries or variation in race of peoples in 
the world (Zafarghandi et al., 1998; Bakhtiari et al., 
2006; Sadjadi et al.,2009; Howlader et al., 2010). The 
finding indicated that patients who received no surgery 
had poorer survival compared to those who received 
mastectomy and lumpectomy. Also, patients who 
received lumpectomy had upper survival compared to 
those who received mastectomy because all cases were 
treated with lumpectomy were alive, but in the group 
treated with mastectomy survival rate was 55% which 
indicates increasing awareness of patients and their on-
time referral for getting a better response to treatment 
and reduce mortality. So, results showed that awareness 
of disease and the impact on the timely diagnosis and 
treatment does not exist in population. In this study, 
chance of survival in urban patient’s twice more than 
rural patients and which is related to high awareness of 
disease, more diagnostic and therapeutic applications at 
cities in province and the possibility of further follow-
up after treatment in urban people compared to rural 
people. 
 However, in studies conducted in different regions 
of Iran, five- year survival rate ranged from 58 to 62 
percent was higher than this study ( Babaee et al., 2005; 
Yaghmayee et al., 2007) and lower survival rate in this 
study compared to other countries and Iran could be 
due to lack of appropriate screening programs, proper 
awareness to patients for repeated examinations and 
information about disease risks. 
 In conclusion, the results of this study suggest that 
the overall 5-year survival rate in Ardebil province was 
lower than other places of Iran and most of countries in 
world and needs to be improved. Also, early diagnosis of 
breast cancer in Ardabil province and design proper and 
extended planning for cancer diagnosis and treatment is 
necessary and essential. 
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